E. Seyfritz

648 total citations
17 papers, 521 citations indexed

About

E. Seyfritz is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, E. Seyfritz has authored 17 papers receiving a total of 521 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in E. Seyfritz's work include Pancreatic function and diabetes (8 papers), Diet, Metabolism, and Disease (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). E. Seyfritz is often cited by papers focused on Pancreatic function and diabetes (8 papers), Diet, Metabolism, and Disease (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). E. Seyfritz collaborates with scholars based in France. E. Seyfritz's co-authors include M. Pinget, S. Sigrist, N. Jeandidier, W. Bietiger, Élisa Maillard, Stéphanie Dal, C. Péronet, Eric Marchioni, Remmelt Van der Werf and A. Langlois and has published in prestigious journals such as PLoS ONE, British Journal of Pharmacology and International Journal of Pharmaceutics.

In The Last Decade

E. Seyfritz

16 papers receiving 515 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Seyfritz France 12 247 136 134 129 106 17 521
C. Péronet France 14 259 1.0× 133 1.0× 133 1.0× 124 1.0× 148 1.4× 19 574
Hadi Khodabandehloo Iran 11 107 0.4× 141 1.0× 153 1.1× 200 1.6× 56 0.5× 19 650
Kahori Egawa Japan 13 82 0.3× 102 0.8× 217 1.6× 297 2.3× 52 0.5× 21 604
Mehrnaz Abbasi United States 13 54 0.2× 70 0.5× 98 0.7× 91 0.7× 34 0.3× 25 376
Miriam Méndez-del Villar Mexico 10 156 0.6× 65 0.5× 106 0.8× 114 0.9× 41 0.4× 21 465
Vigneshwaran Pitchaimani Japan 14 67 0.3× 55 0.4× 61 0.5× 162 1.3× 49 0.5× 23 551
Shizuka Miyashita Japan 12 68 0.3× 97 0.7× 57 0.4× 139 1.1× 37 0.3× 17 515
Sidika E. Karakas United States 10 122 0.5× 52 0.4× 69 0.5× 111 0.9× 38 0.4× 17 434
Inderpal Singh Sidhu India 4 131 0.5× 40 0.3× 73 0.5× 237 1.8× 42 0.4× 9 536

Countries citing papers authored by E. Seyfritz

Since Specialization
Citations

This map shows the geographic impact of E. Seyfritz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Seyfritz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Seyfritz more than expected).

Fields of papers citing papers by E. Seyfritz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Seyfritz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Seyfritz. The network helps show where E. Seyfritz may publish in the future.

Co-authorship network of co-authors of E. Seyfritz

This figure shows the co-authorship network connecting the top 25 collaborators of E. Seyfritz. A scholar is included among the top collaborators of E. Seyfritz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Seyfritz. E. Seyfritz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Dal, Stéphanie, Remmelt Van der Werf, Catherine Walter, et al.. (2018). Treatment of NASH with Antioxidant Therapy: Beneficial Effect of Red Cabbage on Type 2 Diabetic Rats. Oxidative Medicine and Cellular Longevity. 2018(1). 7019573–7019573. 14 indexed citations
2.
Werf, Remmelt Van der, Catherine Walter, W. Bietiger, et al.. (2018). Beneficial effects of cherry consumption as a dietary intervention for metabolic, hepatic and vascular complications in type 2 diabetic rats. Cardiovascular Diabetology. 17(1). 104–104. 16 indexed citations
3.
Mura, Carole, Stéphanie Dal, A. Langlois, et al.. (2016). Impact of the Type of Continuous Insulin Administration on Metabolism in a Diabetic Rat Model. Journal of Diabetes Research. 2016. 1–10. 12 indexed citations
4.
Langlois, A., Carole Mura, W. Bietiger, et al.. (2016). In Vitro and In Vivo Investigation of the Angiogenic Effects of Liraglutide during Islet Transplantation. PLoS ONE. 11(3). e0147068–e0147068. 21 indexed citations
5.
Vivot, Kevin, Mohamed Benahmed, E. Seyfritz, et al.. (2016). A Metabolomic Approach (1H HRMAS NMR Spectroscopy) Supported by Histology to Study Early Post-transplantation Responses in Islet-transplanted Livers. International Journal of Biological Sciences. 12(10). 1168–1180. 4 indexed citations
6.
Werf, Remmelt Van der, W. Bietiger, E. Seyfritz, et al.. (2016). High-fructose and high-fat diet-induced disorders in rats: impact on diabetes risk, hepatic and vascular complications. Nutrition & Metabolism. 13(1). 15–15. 252 indexed citations
7.
Dal, Stéphanie, Remmelt Van der Werf, Catherine Walter, et al.. (2016). Protective effect of antioxidants consumption on diabetes, hepatic and vascular complications: alliance between chemistry and biology. 3(1). 1 indexed citations
8.
Langlois, A., Stéphanie Dal, Kevin Vivot, et al.. (2016). Improvement of islet graft function using liraglutide is correlated with its anti‐inflammatory properties. British Journal of Pharmacology. 173(24). 3443–3453. 27 indexed citations
9.
Dal, Stéphanie, W. Bietiger, E. Seyfritz, et al.. (2015). Oxidative Stress Type Influences the Properties of Antioxidants Containing Polyphenols in RINm5F Beta Cells. Evidence-based Complementary and Alternative Medicine. 2015. 1–11. 13 indexed citations
10.
Dal, Stéphanie, N. Jeandidier, E. Seyfritz, et al.. (2015). Portal or subcutaneous insulin infusion: efficacy and impact on liver inflammation. Fundamental and Clinical Pharmacology. 29(5). 488–498. 15 indexed citations
11.
Dal, Stéphanie, N. Jeandidier, E. Seyfritz, et al.. (2015). Featured Article: Oxidative stress status and liver tissue defenses in diabetic rats during intensive subcutaneous insulin therapy. Experimental Biology and Medicine. 241(2). 184–192. 19 indexed citations
12.
Vivot, Kevin, A. Langlois, W. Bietiger, et al.. (2014). Pro-Inflammatory and Pro-Oxidant Status of Pancreatic Islet In Vitro Is Controlled by TLR-4 and HO-1 Pathways. PLoS ONE. 9(10). e107656–e107656. 29 indexed citations
13.
Dal-Ros, S., W. Bietiger, E. Seyfritz, et al.. (2014). P234 Apports bénéfiques des antioxydants naturels dans la prévention du diabète de type 2 chez l’animal. Diabetes & Metabolism. 40. A83–A83. 2 indexed citations
16.
Reix, Nathalie, Audrey Parat, E. Seyfritz, et al.. (2012). In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles. International Journal of Pharmaceutics. 437(1-2). 213–220. 75 indexed citations
17.
Langlois, A., W. Bietiger, E. Seyfritz, et al.. (2011). Improvement of Rat Islet Viability during Transplantation: Validation of Pharmacological Approach to Induce VEGF Overexpression. Cell Transplantation. 20(9). 1333–1342. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026